Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
09:00-09:15 | 09:00-09:15 |
Pathogenesis and Intervention of Obesity-Related Hypertension |
Zhiming Zhu | Chongqing Institute of Hypertension, Daping Hospital, Army Medical University |
09:15-09:22 | 09:15-09:22 |
Discussion |
||
09:22-09:37 | 09:22-09:37 |
Risk Assessment and Treatment Targets of Hypertensives with Hypercholesterolemia |
Ping Ye | The Second Medical Center of PLA General Hospital |
09:37-09:44 | 09:37-09:44 |
Discussion |
||
09:44-09:59 | 09:44-09:59 |
Treatments for Patients with Hypertension and Hyperuricemia |
Birong Zhou | |
09:59-10:06 | 09:59-10:06 |
Discussion |
||
10:06-10:21 | 10:06-10:21 |
Antihypertensive Effect and Cardiovascular Benefits of SGLT2i and GLP-1RA |
Xiaoping Chen | West China Hospital, Sichuan University |
10:21-10:30 | 10:21-10:30 |
Discussion |
Beijing Time (UTC+8) | Local Time | Presentation Topic | Speaker | Affiliation / Organization |
---|---|---|---|---|
10:30-10:34 | 10:30-10:34 |
Video Display: Because I say so |
||
10:34-10:52 | 10:34-10:52 |
Interpretation of Hotspots in ACC-ISH-ESC: A+ Protocol in Intensive Blood Pressure Treatment
Yuqing Zhang
Beijing Fuwai Hospital /
Liangdi Xie
The First Hospital of Fujian Medical University /
Jing Liu
Peking University People's Hospital
|
||
10:52-11:00 | 10:52-11:00 |
A+ Protocol Is a Preferred Choice for Hypertensive Patients in China
Weizhong Zhang
Shanghai Institute of Hypertension /
Ningling Sun
Peking University People's Hospital /
Jinxiu Lin
The First Affiliated Hospital of Fujian Medical University
|